Angie Purvis, LLC

Executives in diagnostics, medical devices, and pharma need faster, clearer ways to drive innovation. This article shows how advanced data analysis, workflow optimization, and evidence‑driven process development reduce risk, improve product efficiency, and accelerate time‑to‑market for high‑value solutions.

After my most recent post , I received many questions about the different types of blood‑derived specimen collection, preservation, and transport systems. One theme stood out: confusion about how these systems differ and what those differences mean from a regulatory and test performance standpoint. Innovation Is Transforming Blood Collection Over the past decade, specimen collection technologies have evolved rapidly. Many of these innovations are patient‑centered by design, a